Discovery & Development

From regulatory hurdles to patient recruitment challenges; how can pharma improve its clinical trials?

How to mitigate the risks involved in highly potent APIs.

Regular injections to the eye are a reality for many patients. We must come up with better solutions for retinal degenerative diseases.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

Maintaining the stability of vaccines over time and during temperature excursions is a crucial aspect of production, transport, and delivery.

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

Exploring the potential of leriglitazone in helping patients with cerebral X-linked adrenoleukodystrophy.

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research

As 3D printing gains traction in the pharma industry, its potential to revolutionize solid oral dosage forms is becoming clearer.